[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Small Molecule CDMO-Global Market Status and Trend Report 2016-2026

December 2021 | 155 pages | ID: SB2747B91AA6EN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Small Molecule CDMO-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Small Molecule CDMO industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Small Molecule CDMO 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Small Molecule CDMO worldwide, with company and product introduction, position in the Small Molecule CDMO market
Market status and development trend of Small Molecule CDMO by types and applications
Cost and profit status of Small Molecule CDMO, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Small Molecule CDMO market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Small Molecule CDMO industry.

The report segments the global Small Molecule CDMO market as:

Global Small Molecule CDMO Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Small Molecule CDMO Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Development
API Production

Global Small Molecule CDMO Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Pharmaceutical
Biopharmaceutical

Global Small Molecule CDMO Market: Manufacturers Segment Analysis (Company and Product introduction, Small Molecule CDMO Sales Volume, Revenue, Price and Gross Margin):
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SMALL MOLECULE CDMO

1.1 Definition of Small Molecule CDMO in This Report
1.2 Commercial Types of Small Molecule CDMO
  1.2.1 Development
  1.2.2 API Production
1.3 Downstream Application of Small Molecule CDMO
  1.3.1 Pharmaceutical
  1.3.2 Biopharmaceutical
1.4 Development History of Small Molecule CDMO
1.5 Market Status and Trend of Small Molecule CDMO 2016-2026
  1.5.1 Global Small Molecule CDMO Market Status and Trend 2016-2026
  1.5.2 Regional Small Molecule CDMO Market Status and Trend 2016-2026

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Small Molecule CDMO 2016-2021
2.2 Production Market of Small Molecule CDMO by Regions
  2.2.1 Production Volume of Small Molecule CDMO by Regions
  2.2.2 Production Value of Small Molecule CDMO by Regions
2.3 Demand Market of Small Molecule CDMO by Regions
2.4 Production and Demand Status of Small Molecule CDMO by Regions
  2.4.1 Production and Demand Status of Small Molecule CDMO by Regions 2016-2021
  2.4.2 Import and Export Status of Small Molecule CDMO by Regions 2016-2021

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Small Molecule CDMO by Types
3.2 Production Value of Small Molecule CDMO by Types
3.3 Market Forecast of Small Molecule CDMO by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Small Molecule CDMO by Downstream Industry
4.2 Market Forecast of Small Molecule CDMO by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SMALL MOLECULE CDMO

5.1 Global Economy Situation and Trend Overview
5.2 Small Molecule CDMO Downstream Industry Situation and Trend Overview

CHAPTER 6 SMALL MOLECULE CDMO MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Small Molecule CDMO by Major Manufacturers
6.2 Production Value of Small Molecule CDMO by Major Manufacturers
6.3 Basic Information of Small Molecule CDMO by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Small Molecule CDMO Major Manufacturer
  6.3.2 Employees and Revenue Level of Small Molecule CDMO Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 SMALL MOLECULE CDMO MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Lonza
  7.1.1 Company profile
  7.1.2 Representative Small Molecule CDMO Product
  7.1.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Lonza
7.2 Catalent
  7.2.1 Company profile
  7.2.2 Representative Small Molecule CDMO Product
  7.2.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Catalent
7.3 Thermo Fisher
  7.3.1 Company profile
  7.3.2 Representative Small Molecule CDMO Product
  7.3.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Thermo Fisher
7.4 Wuxi Apptec
  7.4.1 Company profile
  7.4.2 Representative Small Molecule CDMO Product
  7.4.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Wuxi Apptec
7.5 PharmaBlock
  7.5.1 Company profile
  7.5.2 Representative Small Molecule CDMO Product
  7.5.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of PharmaBlock
7.6 Asym Chemical
  7.6.1 Company profile
  7.6.2 Representative Small Molecule CDMO Product
  7.6.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Asym Chemical
7.7 Jiuzhou Pharmaceutical
  7.7.1 Company profile
  7.7.2 Representative Small Molecule CDMO Product
  7.7.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Jiuzhou Pharmaceutical
7.8 Pharmaron Beijing
  7.8.1 Company profile
  7.8.2 Representative Small Molecule CDMO Product
  7.8.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Pharmaron Beijing
7.9 Porton Pharma
  7.9.1 Company profile
  7.9.2 Representative Small Molecule CDMO Product
  7.9.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Porton Pharma
7.10 ChemPartner
  7.10.1 Company profile
  7.10.2 Representative Small Molecule CDMO Product
  7.10.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of ChemPartner
7.11 Jiangsu Sinopep
  7.11.1 Company profile
  7.11.2 Representative Small Molecule CDMO Product
  7.11.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Jiangsu Sinopep
7.12 DELPHARM
  7.12.1 Company profile
  7.12.2 Representative Small Molecule CDMO Product
  7.12.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of DELPHARM
7.13 Aenova Group
  7.13.1 Company profile
  7.13.2 Representative Small Molecule CDMO Product
  7.13.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Aenova Group
7.14 Siegfried Holding AG
  7.14.1 Company profile
  7.14.2 Representative Small Molecule CDMO Product
  7.14.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Siegfried Holding AG
7.15 Recipharm AB
  7.15.1 Company profile
  7.15.2 Representative Small Molecule CDMO Product
  7.15.3 Small Molecule CDMO Sales, Revenue, Price and Gross Margin of Recipharm AB
7.16 FAREVA SA
7.17 Almac Group
7.18 Cambrex
7.19 Charles River
7.20 CORDEN PHARMA
7.21 Jubilant Pharmova
7.22 Consort Medical

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SMALL MOLECULE CDMO

8.1 Industry Chain of Small Molecule CDMO
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SMALL MOLECULE CDMO

9.1 Cost Structure Analysis of Small Molecule CDMO
9.2 Raw Materials Cost Analysis of Small Molecule CDMO
9.3 Labor Cost Analysis of Small Molecule CDMO
9.4 Manufacturing Expenses Analysis of Small Molecule CDMO

CHAPTER 10 MARKETING STATUS ANALYSIS OF SMALL MOLECULE CDMO

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications